| Literature DB >> 28948410 |
Rodrigo Martins Pereira1,2, Rania A Mekary3,4, Kellen Cristina da Cruz Rodrigues1,2, Chadi Pellegrini Anaruma1,2, Eduardo Rochete Ropelle1,2, Adelino Sanchez Ramos da Silva5, Dennys Esper Cintra1, José Rodrigo Pauli1,2, Leandro Pereira de Moura6,7.
Abstract
Loss of cardiomyocytes occurs with aging and contributes to cardiovascular complications. In the present study, we highlighted the role of clusterin, a protein that has recently been associated with the protection of cardiomyocytes from apoptosis. Clusterin protects cardiac cells against damage from myocardial infarction, transplant, or myocarditis. Clusterin can act directly or indirectly on apoptosis by regulating several intracellular pathways. These pathways include (1) the oxidant and inflammatory program, (2) insulin growth factor 1 (IGF-1) pathway, (3) KU70 / BCL-2-associated X protein (BAX) pathway, (4) tumor necrosis factor alpha (TNF-α) pathway, (5) BCL-2 antagonist of cell death (BAD) pathway, and (6) mitogen-activated protein kinase (MAPK) pathway. Given the key role of clusterin in preventing loss of cardiac tissue, modulating the expression and function of this protein carries the potential of improving cardiovascular care in the future.Entities:
Keywords: Apolipoprotein J; Apoptosis; Cardiomyocytes; Clusterin; Megalin
Mesh:
Substances:
Year: 2018 PMID: 28948410 DOI: 10.1007/s10741-017-9654-z
Source DB: PubMed Journal: Heart Fail Rev ISSN: 1382-4147 Impact factor: 4.214